Skip to main content

Table 5 Progression free survival and overall survival in advanced gastric cancer patients receiving first-line chemotherapy (multivariate analysis)

From: Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer

Factors

Progression free survival

 

Hazard ratio (95% CI)

P-value

ECOG PS (≥ 2)

1.37 (1.02-1.84)

0.035

CRP (>1)

1.64 (1.28-2.09)

0.001

Bone metastasis

1.74 (1.14-2.65)

0.009

 

Overall survival

 

Hazard ratio (95% CI)

P-value

ECOG PS (≥ 2)

1.33 (1.01-1.76)

0.037

GPS (1)

1.75 (1.37-2.26)

0.001

GPS (2)

1.79 (1.29-2.47)

0.001

Bone metastasis

1.61 (1.08-2.39)

0.017

  1. ECOG PS: Eastern Cooperative Oncology Group, performance status, CRP: C-reactive protein
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us